As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States for the year, with 94% outbreak-associated across 17 new outbreaks and ongoing clusters from 2025 in 33 jurisdictions, including major hotspots in South Carolina, Utah, and Texas. This reflects sustained community transmission in under-vaccinated pockets amid high virus contagiousness (R0 of 12-18), fueled by travel-related imports and gaps below the 95% two-dose MMR coverage needed for herd immunity. Weekly case growth has slowed to a 2.57% increase as of April 10, signaling potential containment efforts, though two weeks remain before April 30 resolution based on rash-onset epidemiological weeks. Traders should watch CDC's weekly surveillance updates and state vaccination campaigns for shifts in trajectory.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCasi di morbillo negli Stati Uniti entro il 30 aprile?
Casi di morbillo negli Stati Uniti entro il 30 aprile?
$189,905 Vol.
$189,905 Vol.
30 apr 2026
1800
58%
1850
19%
1900
6%
1950
4%
2000
3%
2100
2%
2200
2%
$189,905 Vol.
$189,905 Vol.
30 apr 2026
1800
$48,139 Vol.
58%
1850
$4,832 Vol.
19%
1900
$50,744 Vol.
6%
1950
$20,403 Vol.
4%
2000
$42,586 Vol.
3%
2100
$7,273 Vol.
2%
2200
$15,939 Vol.
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States for the year, with 94% outbreak-associated across 17 new outbreaks and ongoing clusters from 2025 in 33 jurisdictions, including major hotspots in South Carolina, Utah, and Texas. This reflects sustained community transmission in under-vaccinated pockets amid high virus contagiousness (R0 of 12-18), fueled by travel-related imports and gaps below the 95% two-dose MMR coverage needed for herd immunity. Weekly case growth has slowed to a 2.57% increase as of April 10, signaling potential containment efforts, though two weeks remain before April 30 resolution based on rash-onset epidemiological weeks. Traders should watch CDC's weekly surveillance updates and state vaccination campaigns for shifts in trajectory.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercato aperto: Mar 27, 2026, 1:49 PM ET
Volume
$189,905Data di fine
30 apr 2026Mercato aperto
Mar 27, 2026, 1:49 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States for the year, with 94% outbreak-associated across 17 new outbreaks and ongoing clusters from 2025 in 33 jurisdictions, including major hotspots in South Carolina, Utah, and Texas. This reflects sustained community transmission in under-vaccinated pockets amid high virus contagiousness (R0 of 12-18), fueled by travel-related imports and gaps below the 95% two-dose MMR coverage needed for herd immunity. Weekly case growth has slowed to a 2.57% increase as of April 10, signaling potential containment efforts, though two weeks remain before April 30 resolution based on rash-onset epidemiological weeks. Traders should watch CDC's weekly surveillance updates and state vaccination campaigns for shifts in trajectory.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$189,905Data di fine
30 apr 2026Mercato aperto
Mar 27, 2026, 1:49 PM ETResolver
0x65070BE91...As of April 9, 2026, the CDC reports 1,714 confirmed measles cases in the United States for the year, with 94% outbreak-associated across 17 new outbreaks and ongoing clusters from 2025 in 33 jurisdictions, including major hotspots in South Carolina, Utah, and Texas. This reflects sustained community transmission in under-vaccinated pockets amid high virus contagiousness (R0 of 12-18), fueled by travel-related imports and gaps below the 95% two-dose MMR coverage needed for herd immunity. Weekly case growth has slowed to a 2.57% increase as of April 10, signaling potential containment efforts, though two weeks remain before April 30 resolution based on rash-onset epidemiological weeks. Traders should watch CDC's weekly surveillance updates and state vaccination campaigns for shifts in trajectory.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti